News
Bone health management varies across hospitals for older women with early breast cancer who have inconsistent bone density ...
Breast cancer rates are on the rise, and doctors fear that alcohol could be a big reason why. CNN’s Meg Tirrell speaks to an ...
A 54-year-old patient’s routine mammogram finds a 6-mm breast nodule that histology confirms as kidney cancer metastasis, 3 ...
A major investigation is under way into the care of thousands of breast cancer patients at a hospital trust. The County ...
5d
MedPage Today on MSNYoung Breast Cancer Patients Had Low Risk of Locoregional Recurrence After SurgeryAmong a cohort of 1,135 women ages 40 and younger with stage I through III breast cancer, the incidence of LRR was 5.6%, with ...
We need to encourage doctors to ask their male patients about their risk factors for breast cancer and examine their chest ...
Gedatolisib combined with Faslodex and Ibrance improved progression-free survival in patients with advanced breast cancer ...
A Northeastern University researcher has identified a way to target two of the deadliest cancer types, melanoma and triple ...
A new documentary shines light on battling breast cancer. "One in Eight" shares the journey of 10 women living in and around ...
A phase 3 trial of Celcuity’s breast cancer combination has hit its primary endpoints, blasting past the biotech’s bar for ...
Celcuity said on Monday its experimental combination treatment delayed the progression of a type of advanced breast cancer in a late-stage study, sending the biotech firm's shares surging to a record ...
Celcuity’s stock jumps after Phase 3 trial shows gedatolisib slashes progression risk in breast cancer patients by up to 76%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results